KRMD logo

KORU MEDICAL SYSTEMS INC

KRMDNASDAQ
πŸ† #3904 by market capUS Equity
$469.12β–² $17.97 (+3.83%)
Simulated price
πŸ””
Track KRMD
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 3.8%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$141M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+22.2%
Healthy
πŸ“ŠGross Margin
62.0%
High
πŸ’΅FCF Margin
0.6%
Thin
βš–οΈP/S Ratio
3.1x
Fair
Otter Score
64
Fair
No chart data available for KRMD.

Trading Snapshot

Day Range
$466.40 – $476.66
52-Week Range
$2.99 – $6.61
Volume
$3.09B
Avg Volume
$3.05B
Shares Outstanding
45.9M
Next Earnings
Nov 21, 2026

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
-78.1
P/S Ratio
3.1x
EPS (TTM)
$-0.04
Dividend Yield
0.00%
Dilution (1yr)
+0.6%

Why Investors Own KRMD

  • βœ“High-growth profile β€” revenue up +36.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 37% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

KRMD logo

KORU MEDICAL SYSTEMS INC

KRMD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$41Mβ–² +22.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
62.3%β–Ό βˆ’1.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$3Mβ–Ό βˆ’53.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$470Kβ–Ό βˆ’70.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
46.2Mβ–² +0.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5Mβ–Ό βˆ’$215K YoY
StockOtter Β· stockotter.space

About KORU MEDICAL SYSTEMS INC

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$474.62
β–² +1.2% Upside
High Target$581.47
Low Target$445.00
Based on 12 analysts

Latest News & Updates